![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Siegfried Ltd Zofingen Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Selegiline hydrochloride, Helos 10%, Helos 50% and Helos 90%, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2005-272 - Rev 01
This Chemical Type CEP, issued on July 06, 2012, remains in force until January 14, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 1260 associated with this CEP further emphasizes